Cataract is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Basics

Description

  • A cataract is any opacity or discoloration of the lens, localized or generalized; the term is usually reserved for changes that affect visual acuity (1,2).
  • Etymology: from Latin catarractes, for “waterfall”; named after foamy appearance of opacity
  • Leading cause of blindness worldwide, estimated 20 million people (1,2)
  • Types include the following:
    • Age related: 90% of total
    • Metabolic (diabetes via accelerated sorbitol pathway, hypocalcemia, Wilson disease)
    • Congenital (1/250 newborns; 10–38% of childhood blindness)
    • Systemic disease associated (myotonic dystrophy, atopic dermatitis [AD])
    • Secondary to associated eye disease, so-called complicated (e.g., uveitis associated with juvenile rheumatoid arthritis or sarcoid, tumor such as melanoma or retinoblastoma)
    • Traumatic (e.g., heat, electric shock, radiation, concussion, perforating eye injuries, intraocular foreign body)
    • Toxic/nutritional (e.g., corticosteroids)
  • Morphologic classification:
    • Nuclear: exaggeration of normal aging changes of central lens nucleus, often associated with myopia due to increased refractive index of lens (Some elderly patients consequently may be able to read again without spectacles, so-called second sight of the aged.)
    • Cortical: outer portion of lens; may involve anterior, posterior, or equatorial cortex; radial, spoke-like opacities
    • Subcapsular: Posterior subcapsular cataract has more profound effect on vision than nuclear or cortical cataract; patients particularly troubled under conditions of miosis; near vision frequently impaired more than distance vision
  • System(s) affected: nervous

Geriatric Considerations
Some degree of cataract formation is expected in all people >70 years of age.

Pediatric Considerations
See Congenital cataract; may present as leukocoria

Pregnancy Considerations
See Congenital cataract (i.e., medications, metabolic dysfunction, intrauterine infection, and malnutrition).

Epidemiology

Incidence
  • ~48% of the 37 million cases of blindness worldwide result from cataracts (1,2).
  • Leading cause of treatable blindness and vision loss in developing countries (1,2)
  • Predominant age: depends on type of cataract
  • Predominant sex: male > female

Prevalence
  • Cataract type and prevalence are highly variable based on population demographic.
  • An estimated 50% of people 65 to 74 years of age and 70% of people >75 years of age have age-related cataract.

Etiology and Pathophysiology

  • Age-related cataract:
    • Continual addition of layers of lens fibers throughout life creates hard, dehydrated lens nucleus that impairs vision (nuclear cataract).
    • Aging alters biochemical and osmotic balance required for lens clarity; outer lens layers hydrate and become opaque, adversely affecting vision.
  • Congenital:
    • Usually unknown etiology
    • Drugs (corticosteroids in 1st trimester, sulfonamides)
    • Metabolic (diabetes in mother, galactosemia in fetus)
    • Intrauterine infection during 1st trimester (e.g., rubella, herpes, mumps)
    • Maternal malnutrition
  • Other cataract types:
    • Common feature is a biochemical/osmotic imbalance that disrupts lens clarity.
    • Local changes in lens protein distribution lead to light scattering (lens opacity).

Genetics
  • Congenital (e.g., chromosomal disorders [Down syndrome])
  • Genetics of age-related cataract are not yet established but likely multifactorial contribution.

Risk Factors

  • Aging
  • Cigarette smoking
  • Ultraviolet (UV) sunlight exposure
  • Diabetes
  • Prolonged high-dose steroids
  • Positive family history
  • Alcohol

General Prevention

  • Use of UV protective glasses
  • Avoidance of tobacco products
  • Effective control of diabetes
  • Care with high-dose, long-term steroid use (systemic therapy > inhaled treatment)
  • Protective methods using pharmaceutical intervention (e.g., antioxidants, acetylsalicylic acid [ASA], hormone replacement therapy [HRT]) show no proven benefit to date.

Commonly Associated Conditions

  • Diabetes (especially with poor glucose control)
  • Myotonic dystrophy (90% of patients develop visually innocuous change in 3rd decade; becomes disabling in 5th decade)
  • AD (10% of patients with severe AD develop cataracts in 2nd to 4th decades; often bilateral)
  • Neurofibromatosis type 2
  • Associated ocular disease or “secondary cataract” (e.g., chronic anterior uveitis, acute [or repetitive] angle-closure glaucoma or high myopia)
  • Drug induced (e.g., steroids, chlorpromazine)
  • Trauma

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Cataract ID - 116108 ED - Baldor,Robert A, ED - Domino,Frank J, ED - Golding,Jeremy, ED - Stephens,Mark B, BT - 5-Minute Clinical Consult, Updating UR - https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116108/all/Cataract PB - Wolters Kluwer ET - 27 DB - Medicine Central DP - Unbound Medicine ER -